Weight loss drugs risk worsening eating disorders
The increasing use of obesity medications from the GLP-1 class, such as Ozempic, Wegovy, and Zybound, is likely to exacerbate eating disorders, especially among those suffering from anorexia nervosa and bulimia. These drugs are easily accessible online and are often obtained without comprehensive psychological and medical evaluations. Cases have shown that unregulated use can lead to malnutrition and serious health complications, with experts emphasizing the importance of accurate diagnosis before prescribing these medications.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)